---
title: "YUYUE MEDICAL: Overseas revenue maintained rapid growth in the first three quarters"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262775881.md"
description: "YUYUE MEDICAL stated in an institutional research report that overseas revenue continued to grow rapidly in the first three quarters, especially in the Southeast Asian and European markets. The localization strategy in the Thai market will be promoted to Indonesia and Vietnam. The company achieved rapid growth in the European market and established a scientific advisory committee in the field of respiratory therapy to enhance brand influence. Revenue in the North American market saw significant growth, with the strategic cooperation with Inogen continuing to deepen, and the South American market also resumed rapid growth in the third quarter"
datetime: "2025-10-26T13:09:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262775881.md)
  - [en](https://longbridge.com/en/news/262775881.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262775881.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/262775881.md) | [繁體中文](https://longbridge.com/zh-HK/news/262775881.md)


# YUYUE MEDICAL: Overseas revenue maintained rapid growth in the first three quarters

YUYUE MEDICAL stated during an institutional research that in the first three quarters, the company's overseas revenue maintained a high-speed growth trend. In the Southeast Asian market, revenue in the Thailand region continued to show strong growth. The company will use the localized approach of "from product export to ecological co-construction" in the Thai market as a template to promote it to other countries such as Indonesia and Vietnam. During the reporting period, the company achieved rapid growth in the European market, where respiratory therapy products successfully broke into several key countries. At the same time, the company established a scientific advisory committee in the field of respiratory therapy in Europe, aiming to strengthen the company's brand influence locally through clinical academic resources, thereby promoting product introduction into the local market. During the reporting period, revenue in the North American market achieved significant growth, and the company continued to deepen its strategic cooperation with Inogen, actively promoting the progress of subsequent product registrations. Revenue in the South American market recovered rapidly in the third quarter

### Related Stocks

- [YUYUE MEDICAL (002223.CN)](https://longbridge.com/en/quote/002223.CN.md)

## Related News & Research

- [These two sleep disorders together may triple heart disease risk: Study](https://longbridge.com/en/news/278511533.md)
- [HCM City expo connects businesses across nonwoven and hygiene value chain](https://longbridge.com/en/news/278818693.md)
- [Vietnam Airlines seeks environment tax exemption on jet fuel](https://longbridge.com/en/news/278369319.md)
- [Việt Nam steps up cooperation with US businesses to attract international capital](https://longbridge.com/en/news/278328829.md)
- [Việt Nam building 27 mega real estate projects worth more than $115 billion, report says](https://longbridge.com/en/news/278648003.md)